Medtronic recalls Clinician Programmer Application software versions 3.0.1048-1081 for potential software anomalies. Affected users should check their software version and contact Medtronic for updates.
“Medtronic CPA Software A610 Recall: Software Anomaly Risk.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/61759-medtronic-cpa-software-a610-recall-software-anomaly-risk. Based on FDA recall #Z-0201-2022 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0201-2022%22&limit=1).
The FDA announced on 2021-09-23 that Medtronic Neuromodulation is recalling the Clinician Programmer Application (CPA) model A610 due to a software anomaly. The agency issued recall number Z-0201-2022 for the device.
How to tell if you have it
Clinician Programmer Application (CPA) model A610
version 3.0.1048
version 3.0.1057
version 3.0.1062
version 3.0.1081
The hazard
According to the FDA, a software anomaly may occur with the clinician programmer application.
Context
GovInfoNow's records show Medtronic Neuromodulation has 45 other recalls on record since 2017-08-09. Other recent recalls of similar products include Medtronic SynchroMed Flex Infusion Software Issue (2026-04-08), Medtronic Vanta CP App Software Recall (2025-12-03), Edan Central Monitoring System Recall (2025-10-24), Fresenius Medical Care 5008X CAREsystem Recall (2025-10-25), and Edan Central Monitoring System Recall (2025-10-24).
How to tell if you have this one
Check if your software version is 3.0.1048, 3.0.1057, 3.0.1062, or 3.0.1081. The software is part of Medtronic's Clinician Programmer Application (CPA) model A610.
Brand
Medtronic Neuromodulation
Category
Medical device
Based on the official FDA remedy
What to do — step by step
Check Software Version
Identify your software version by checking the Clinician Programmer Application (CPA) model A610 version number.
Contact Medtronic
Reach out to Medtronic for guidance on updating or replacing the software.
Where it went and when
Where it was distributed
Distributed nationwide, and outside the U.S.
Nationwide
Not listed
FDA distribution: “Worldwide distribution - US Nationwide distribution and the countries of Australia, New Zealand, Canada, Europe, India, Japan, Korea, Middle East, Latin America, Africa, SE Asia and China.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide, and outside the U.S.
Recall timeline
FDA published this recall 48 days after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #Z-0201-2022 (September 23, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0201-2022 to see it in context.
Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.